D-0285-2022 Class III Terminated
FDA drug recall D-0285-2022 was initiated by Torrent Pharma Inc. on Dec 1, 2021 and is designated Class III. Reason for recall: Superpotent; Hydrochlorothiazide The recall status is terminated (terminated May 12, 2024). Affected quantity: 27,312 Bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 22, 2021
- Initiation Date
- Dec 1, 2021
- Termination Date
- May 12, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 27,312 Bottles
Product description
Telmisartan and Hydrochlorothiazide Tablets, USP, 40 mg/12.5 mg, 30 count bottles, Rx only, Manufactured by: Torrent Pharmaceuticals LTD., Indrad-382 721, India. Manufactured for: Torrent Pharma Inc., Basking Ridge, NJ 07920. NDC: 13668-159-30
Reason for recall
Superpotent; Hydrochlorothiazide
Distribution pattern
Nationwide USA
Code information
Batch: BZ74G001 Exp. 12/2021.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0285-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026